News

SPARK-BIH and NeuroCure organized a second Design Thinking workshop.

After the successful implementation of the NeuroCure/SPARK program, NeuroCure and SPARK-BIH prolong their collaboration and will run a second call for projects.

Researchers led by our SPARKee Ulrike Stein of the ECRC and Robert Preißner of Charité report in "Clinical and Translational Medicine" that statins inhibit a gene that promotes cancer cell metastasis.

NeuroCure grants funding extension to the four NeuroCure/SPARK-BIH teams for an additional year.

Our SPARKees Simone Spuler und Verena Schöwel present their startup MyoPax in Frank Thelen's Podcast Startup-DNA.

The Charité Spin-off BODYCLOCK Technologies by Prof. Dr. Achim Kramer developed a diagnostic assay to assess the circadian clock. The project has previously been supported by SPARK-BIH and BIH Digital Health Accelerator.

The SPARK Europe network is growing once again with a new charter in Denmark being established.

Two SPARK-BIH funded teams network with investors and the life science industry at the international JPM BIO Partnering Event.

SPARK Europe has joint forces for education on translational research and technology transfer! For the third time, European SPARK sites will host a joint webinar series during spring 2022.

SPARK-BIH and the Stiftung Charité celebrated the end of its I4H Pilot Program with a final I4H Pitch Event on December 13.